Search

everythinglearnresearchcommunity

for

Search:↓

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Feminizing hormone therapy increases kidney filtration rate.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.